It showed pharmacological anti-inflammatory and anti-invasive effects on two aggressive in vitro cancer cell models, the U87 glioblastoma and MDA-MB-231 TNBC cells, against four different pro-inflammatory cues (ConA, PMA, TNFα and TGFβ). This evidence concerns the gene TGFB1 and glioblastoma.